Updated ambulatory glucose profile produced following review
An updated ambulatory glucose profile report featuring the core continuous glucose monitoring metrics and a visualisation of glucose patterns needing clinical attention has been published.
The article, published in Diabetes Technology & Therapeutics, displays a two-week consolidated glucose profile and daily glucose views to help determine what management changes would be most appropriate.
A common set of continuous glucose monitoring (CGM) metrics was proposed in 2017 by an international expert panel, including standard definitions of time in ranges, glucose variability, and adequacy of data collection.
This study by International Diabetes Center at Park Nicollet, in Minneapolis, Minnesota, describes the core CGM metrics, as well as the standardised glucose profile format consolidating two weeks of CGM measurements, referred to as the ambulatory glucose profile (AGP), recommended by the panel.
It reviews new tools for use by clinicians and people with diabetes to interpret AGP data. Additionally, strategies are highlighted, which are based on the authors’ experience in implementing CGM technology across the clinical care spectrum.
Summarising, the researchers said: “Use of CGM is recognised as a valuable component of diabetes self-management and is now considered a standard of care for individuals with diabetes who are treated with intensive insulin therapy. Numerous studies have demonstrated the clinical benefits of CGM use in individuals with T1D and T2D who are treated with MDI or insulin pumps.
“The AGP report displays the key CGM metrics agreed upon by numerous CGM consensus reports which inform clinicians and patients if additional glucose management changes are needed. In addition, the AGP displays a two-week consolidated glucose profile and daily glucose views to help determine what management changes would be most appropriate. The AGP further supports the clinical utility of CGM by replacing device-specific reports with a standardised presentation of the data that may result in faster, more accurate interpretation while minimising the need for multiple software programs and connecting cables. Further development of decision support tools and management recommendations is underway to assist providers and patients in maximising the benefits of using CGM.”
To access the paper Utilizing the Ambulatory Glucose Profile to Standardize and Implement Continuous Glucose Monitoring in Clinical Practice, click here.